ARCHIVES

In Brief: NIH Conference To Explore Conflict Of Interest Issues; Five NCUI Executive Win PHS Awards

This article is from The Cancer Letter archive.

Vol. 15 No. 21 | May 26, 1989

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Lung Cancer Drug Discovery Project, First Targeted Anticancer Agent Search

June 22, 1984

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

Maryland’s Greenebaum Cancer Center Wins NCI Designation.

September 12, 2008

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken.

May 7, 2004